A new wave of radioligand therapies is approaching. With healthcare systems and policymakers ill-equipped to handle the change, Belgium is launching an action plan.
International stakeholders and countries have already expressed interest in expanding this initiative to other European member states.
Radioligand therapy (RLT) is an emerging cancer treatment targeting cancer cells throughout the body while sparing healthy ones. Europe faces challenges integrating RLT into its healthcare systems, with accessibility not keeping pace with innovation and risking unrealised potential without the necessary infrastructure, resources, and…
